Laureate Pharma

About:

Laureate Pharma was a contract manufacturing organization that provided development and cGMP manufacturing services.

Website: http://www.laureatepharma.com

Top Investors: Saints Capital

Description:

Laureate Pharma, Inc., a contract manufacturing organization, provides development and cGMP manufacturing services. It focuses on mammalian cell based monoclonal antibody and recombinant protein production for clinical and commercial supply. The company's biopharmaceutical production/biotherapeutics production services include cGMP production and purification, protein modification and conjugation, formulation and aseptic filling into vials and finishing, upstream and downstream process development, Cell Line Optimization, medium optimization studies and adapting cells to protein-free medium, pilot-scale bioreactor runs, and product formulation development. Its services also comprise transfection, cloning, and selection to create new cell lines; analytical method transfer, development, and qualification; and preclinical production, monoclonal antibody production, and clinical trials manufacturing. Laureate Pharma supports the development and commercialization of biopharmaceutical, drug, and diagnostic products for pharmaceutical, diagnostic, and biotech companies. The company was formerly known as Bard Biopharma L.P. and changed its name to Laureate Pharma, Inc. in 2002. The company is headquartered in Princeton, New Jersey.